Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...

The production of new nurses to help address national nursing shortages starts with the educational pipeline. However, ...

Medicenna Therapeutics Corp ( ($TSE:MDNA) ) has shared an update. Medicenna Therapeutics announced a live webinar to discuss updated clinical data ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

A study of aging mice showed that voluntary exercise over 30 days increased striatal dopamine release and improved motor ...

UAE, Dubai: The Emirates Drug Establishment (EDE), in collaboration with the Drug Information Association (DIA), Middle East ...

UNIONDALE, NY / ACCESS Newswire / December 8, 2025 / Marquis Who’s Who, the trusted biographical authority documenting ...

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...

The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found additional appropriate patients beyond that. "The analysis was unambiguous: ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

In an updated report, Wave Life Sciences Ltd (NASDAQ:WVE) said that enrolled patients who took 240 mg of its drug candidate, ...